Suppr超能文献

11-去氧皮质酮导致代谢综合征,而敲除雄性小鼠肝脏中的 11β-HSD1 则可以预防该综合征。

11-Dehydrocorticosterone causes metabolic syndrome, which is prevented when 11β-HSD1 is knocked out in livers of male mice.

机构信息

Faculty of Life Sciences, AV Hill Building, University of Manchester, Manchester, M13 9PT, United Kingdom.

出版信息

Endocrinology. 2013 Oct;154(10):3599-609. doi: 10.1210/en.2013-1362. Epub 2013 Jul 5.

Abstract

Metabolic syndrome is growing in importance with the rising levels of obesity, type 2 diabetes, and insulin resistance. Metabolic syndrome shares many characteristics with Cushing's syndrome, which has led to investigation of the link between excess glucocorticoids and metabolic syndrome. Indeed, increased glucocorticoids from intracellular regeneration by 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) drives insulin resistance and increases adiposity, but these metabolic changes are assumed to be due to increased circulating glucocorticoids. We hypothesized that increasing the substrate for 11β-HSD1 (11-dehydrocorticosterone, 11-DHC) would adversely affect metabolic parameters. We found that chronic administration of 11-DHC to male C57BL/6J mice resulted in increased circulating glucocorticoids, and down-regulation of the hypothalamic-pituitary-adrenal axis. This elevated 11β-HSD1-derived corticosterone led to increased body weight gain and adiposity and produced marked insulin resistance. Surprisingly liver-specific 11β-HSD1 knockout (LKO) mice given 11-DHC did not show any of the adverse metabolic effects seen in wild-type mice. This occurred despite the 11-DHC administration resulting in elevated circulating corticosterone, presumably from adipose tissue. Mice with global deletion of 11β-HSD1 (global knockout) were unaffected by treatment with 11-DHC, having no increase in circulating corticosterone and exhibiting no signs of metabolic impairment. Taken together, these data show that in the absence of 11β-HSD1 in the liver, mice are protected from the metabolic effects of 11-DHC administration, even though circulating glucocorticoids are increased. This implies that liver-derived intratissue glucocorticoids, rather than circulating glucocorticoids, contribute significantly to the development of metabolic syndrome and suggest that local action within hepatic tissue mediates these effects.

摘要

代谢综合征随着肥胖症、2 型糖尿病和胰岛素抵抗水平的升高而变得越来越重要。代谢综合征与库欣综合征有许多共同特征,这导致了人们对过多糖皮质激素与代谢综合征之间联系的研究。事实上,细胞内 11β-羟类固醇脱氢酶 1(11β-HSD1)的再生导致了胰岛素抵抗和脂肪量增加,但是这些代谢变化被认为是由于循环糖皮质激素增加所致。我们假设增加 11β-HSD1 的底物(11-脱氢皮质酮,11-DHC)会对代谢参数产生不利影响。我们发现,慢性给予 11-DHC 雄性 C57BL/6J 小鼠会导致循环糖皮质激素增加,并下调下丘脑-垂体-肾上腺轴。这种升高的 11β-HSD1 衍生的皮质酮导致体重增加和肥胖,并产生明显的胰岛素抵抗。令人惊讶的是,给予 11-DHC 的肝脏特异性 11β-HSD1 敲除(LKO)小鼠没有表现出野生型小鼠中看到的任何不良代谢作用。尽管 11-DHC 给药导致循环皮质酮升高,这可能来自脂肪组织,但这种情况仍会发生。缺乏 11β-HSD1 的全身性敲除(全身性敲除)小鼠不受 11-DHC 治疗的影响,其循环皮质酮没有增加,也没有表现出代谢损伤的迹象。总之,这些数据表明,在肝脏中缺乏 11β-HSD1 的情况下,即使循环糖皮质激素增加,小鼠也能免受 11-DHC 给药的代谢影响。这意味着肝脏来源的组织内糖皮质激素,而不是循环糖皮质激素,对代谢综合征的发展有重要贡献,并表明肝组织内的局部作用介导了这些作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验